These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21913060)

  • 1. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
    Pinker-Domenig K; Bogner W; Gruber S; Bickel H; Duffy S; Schernthaner M; Dubsky P; Pluschnig U; Rudas M; Trattnig S; Helbich TH
    Eur Radiol; 2012 Feb; 22(2):322-30. PubMed ID: 21913060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
    Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
    El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
    Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
    Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
    Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value of BI-RADS MR imaging.
    Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
    Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
    Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
    Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
    Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
    Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
    Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
    AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
    Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
    Aslan Ö; Oktay A; Eroğlu F
    Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
    Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
    Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?
    Kamal RM; Helal MH; Mansour SM; Haggag MA; Nada OM; Farahat IG; Alieldin NH
    Br J Radiol; 2016 Aug; 89(1064):20160157. PubMed ID: 27327403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy.
    Fujiwara K; Yamada T; Kanemaki Y; Okamoto S; Kojima Y; Tsugawa K; Nakajima Y
    AJR Am J Roentgenol; 2018 Mar; 210(3):W118-W127. PubMed ID: 29381382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.